- What is Gaia Bio's primary focus?
- Gaia Bio focuses on using a new gene editing technology and proprietary methodology to significantly increase the yields of precision fermentation processes and the effectiveness of bacterial bioremediation and biomining processes.
- What is Gaia Bio's innovative approach to bacterial engineering?
- Gaia Bio's innovative approach enables it to engineer a wide array of environmental/wild-type bacteria, which is critical for bioleaching and biomining applications that require bacteria to thrive in acidic environments. This contrasts with other companies that can effectively engineer only a limited set of lab-type bacteria.
- What is the potential yield increase offered by Gaia Bio's method?
- Gaia Bio's method can provide up to a fivefold increase in the yield of bacteria-based products by identifying the most suitable host bacteria for the production of a specific biological product.
- When was Gaia Bio founded?
- Gaia Bio was founded in December 2021.
- What is Gaia Bio's current funding stage?
- Gaia Bio is currently in the Seed funding stage.
- Which investor has participated in Gaia Bio's funding rounds?
- VentureIsrael has participated in Gaia Bio's funding rounds, including those in June 2022, October 2024, and September 2025.
- What is Gaia Bio's primary sector classification?
- Gaia Bio's primary sector classification is Industrial Technologies.
- What are some of the target customer industries for Gaia Bio?
- Gaia Bio targets customers in industries such as Energy, Utilities & Waste Management, Agriculture & Food (including Livestock, Beef, Dairy, and Poultry), Healthcare & Life Sciences (including Cosmetics, Pharmaceuticals, and Biotechnology), and Defense, Safety & Security.
